Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
53.92B | 61.01B | 59.53B | 56.50B | 53.17B | 52.71B | Gross Profit |
17.16B | 19.73B | 19.04B | 17.98B | 16.73B | 15.99B | EBIT |
3.05B | 3.90B | 3.70B | 3.34B | 2.94B | 2.37B | EBITDA |
5.96B | 6.91B | 6.64B | 6.17B | 5.79B | 4.96B | Net Income Common Stockholders |
2.00B | 2.17B | 2.10B | 1.92B | 1.88B | 1.11B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
2.11B | 2.11B | 1.95B | 1.93B | 2.44B | 1.94B | Total Assets |
40.88B | 40.88B | 38.98B | 38.15B | 36.61B | 35.87B | Total Debt |
19.18B | 19.18B | 18.17B | 17.61B | 16.55B | 16.61B | Net Debt |
17.72B | 17.72B | 16.68B | 16.00B | 14.58B | 14.94B | Total Liabilities |
29.61B | 29.61B | 27.36B | 26.69B | 24.88B | 24.75B | Stockholders Equity |
11.09B | 11.09B | 11.46B | 11.30B | 11.57B | 10.99B |
Cash Flow | Free Cash Flow | ||||
3.24B | 3.60B | 3.58B | 3.18B | 3.65B | 4.03B | Operating Cash Flow |
4.45B | 5.80B | 5.65B | 4.75B | 4.83B | 5.19B | Investing Cash Flow |
-1.91B | -2.02B | -1.84B | -2.37B | -1.27B | -1.38B | Financing Cash Flow |
-2.95B | -3.82B | -3.93B | -2.75B | -3.25B | -3.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | C$21.32B | 22.52 | 13.78% | 1.42% | 1.59% | -1.98% | |
78 Outperform | $59.63B | 28.10 | 19.33% | 1.06% | 2.49% | 7.16% | |
78 Outperform | C$10.78B | 16.38 | 12.64% | 1.70% | 1.05% | -6.94% | |
77 Outperform | C$65.16B | 18.30 | 18.66% | 1.07% | 11.62% | -8.08% | |
76 Outperform | $41.85B | 36.16 | 152.86% | 0.25% | 9.30% | 16.85% | |
69 Neutral | C$2.47B | 18.87 | 18.50% | 3.17% | 3.28% | 1.42% | |
62 Neutral | $20.34B | 13.97 | -16.14% | 3.32% | 1.30% | 5.01% |
Loblaw Companies Limited has initiated an automatic share purchase plan (ASPP) to facilitate the repurchase of its common shares under its normal course issuer bid (NCIB), which allows for the purchase of up to 5% of its outstanding shares. This move is designed to enable share repurchases during periods when the company is restricted from market activity due to insider trading rules, potentially impacting its stock liquidity and shareholder value.
Loblaw Companies Limited reported a significant growth in adjusted diluted net earnings per common share for the fourth quarter and fiscal year 2024, driven by strong operational and financial results. The company experienced increased customer engagement through personalized loyalty offers and effective in-store promotions, leading to higher traffic and market share gains in Food Retail. Drug Retail also performed well, with growth in beauty categories despite the exit from certain electronics sales. Over the year, Loblaw expanded its network by opening new stores and clinics and plans further expansions in 2025. The opening of its first T&T Supermarket in the United States marked a major milestone, highlighting Loblaw’s strategic positioning to meet diverse consumer needs.